Mode of action of pertuzumab in combination with trastuzumab plus docetaxel therapy in a HER2-positive breast cancer xenograft modelYoriko Yamashita‐Kashima, Naoki HaradaOncology LettersJuly 26, 201710.3892/ol.2017.6679Cited by 25SaveCiteExport RISWatch citationsRelated PapersEnhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model|Oncology Reports|2013|46Biomarkers for antitumor activity of bevacizumab in gastric cancer models|BMC Cancer|2012|32